State Of Wyoming Neogenomics Inc Transaction History

State Of Wyoming

$723 Million
Q1 2025

A detailed history of State Of Wyoming transactions in Neogenomics Inc stock. As of the latest transaction made, State Of Wyoming holds 4,051 shares of NEO stock, worth $21,267. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,051

Previous 3,793 6.8%

Holding current value

$21,267

Previous $62,000 38.71%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$9.09 - $18.61 $2,345 - $4,801	258 Added 6.8%	4,051 $38,000
Q4 2024 Feb 14, 2025	BUY	$13.0 - $18.43 $7,111 - $10,081	547 Added 16.85%	3,793 $62,000
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $43,496 - $57,551	3,246 New	3,246 $47,000
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $36,153 - $64,221	3,098 New	3,098 $50,000
Q2 2023 Aug 14, 2023	SELL	$14.1 - $19.83 $56,442 - $79,379	-4,003 Reduced 71.51%	1,595 $25,000
Q1 2023 May 12, 2023	SELL	$9.09 - $19.45 $98,917 - $211,654	-10,882 Reduced 66.03%	5,598 $97,000
Q4 2022 Feb 14, 2023	BUY	$6.45 - $12.07 $49,574 - $92,770	7,686 Added 87.4%	16,480 $152,000
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $46,263 - $75,988	5,886 Added 202.41%	8,794 $76,000
Q2 2022 Aug 15, 2022	SELL	$7.06 - $13.97 $3,501 - $6,929	-496 Reduced 14.57%	2,908 $24,000
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $2,344 - $6,809	193 Added 6.01%	3,404 $41,000
Q4 2021 Feb 11, 2022	SELL	$30.49 - $48.49 $3,414 - $5,430	-112 Reduced 3.37%	3,211 $110,000
Q3 2021 Feb 11, 2022	BUY	$41.66 - $52.52 $44,242 - $55,776	1,062 Added 46.97%	3,323 $160,000
Q2 2021 Feb 11, 2022	BUY	$36.62 - $51.69 $82,797 - $116,871	2,261 New	2,261 $102,000

Others Institutions Holding NEO

# of Institutions

279

Shares Held

127M

Call Options Held

942K

Put Options Held

172K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $660M
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account